Delhi Summit 2007 - Scientific Program - Session IV
Chairs:
Dr. Ganguly, Director General ICMR, New Delhi, India
Dr. J. Fareed, Professor, Loyola University Medical Center, USA
Dr. G. Rao, Professor, University of Minnesota, USA
| 04:50 - 05:00 PM |
Recommendations for Approval of Generic Drugs such as Antithrombotics
W. Leong - Walter Jeske - E. Kalodiki |
| 05:00 - 05:10 PM |
Limitations of Current Guidelines
G. Rao - M. Walter Jeske - E. Kalodiki |
| 05:10 - 05:20 PM |
Ongoing Discussions on Biosimilar - Biogeneric and Biotechnologic Drugs
C. Jackson - F. Ofosu |
| 05:20 - 05:30 PM |
Regulatory Agencies and Their Position in North America
R. Hull - R. Wahi - W. Leong - A. Sasahara (Corresponding) |
| |
Regulatory Agencies and Their Position in Europe
W. Raake - E. Kalodiki - B. Kaiser |
| 05:40 - 05:50 PM |
Regulatory Agencies and Their Position in South East Asia
R. Saxena - V. Muthuswamy (Deputy Director, ICMR) |
| 05:50 - 06:00 PM |
Regulatory Agencies and Their Position in Central and South American
H. Nader - R. Altman (Corresponding) |
| 06:00 - 06:10 PM |
Position of the Professional Organizations (EU, ICAT, SASAT, ASH, ACCP, ACS)
J. Fareed - I. Hussain - A. Nicolaides (Corresponding) |
| 06:10 - 06:20 PM |
Position of the Industry and Pharmacopeial Organizations
P. Bianchini (European Pharmacopeial Commission)
U. Cornelli (Corresponding) |
| 06:20 - 06:40 PM |
Summary and Recommendations for the White Paper
Moderators: J. Fareed - G. Rao - R. Hull - W. Leong
Panelists: Cecil Ross, Das Gupta, Reena Das,
Sharath Damodar, Renu Saxena, Dipika Mohanty, Vijay Arora,
Anjali Arora, Sateesh Babu, Rakesh Wahi |
| 06:40 - 06:45 PM |
Closing Remarks
Dr. J. Fareed, Professor, Loyola University Medical Center, USA |
Back to Scientific Program Overview
|
